Syncom Formulations (India) informs about revised audited financial results

26 Jun 2018 Evaluate

Syncom Formulations (India) has informed about submission of the Revised Audited Financial Results along with the Auditors Report and Reconciliation Statement of Equity for the Quarter/Year ended 31st March, 2018.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

12.97 0.02 (0.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×